Form 4: Privia Health CEO Parth Mehrotra Sells 121,086 Shares
Statement of Changes in Beneficial Ownership
Privia Health Group CEO Parth Mehrotra executed a planned sale of 121,086 shares of common stock for tax and trading plan purposes.
Summary
- CEO Parth Mehrotra sold a total of 121,086 shares of Privia Health Group common stock on May 11 and May 12, 2026.
- The transactions were executed under a Rule 10b5-1 trading plan.
- A portion of the sales were 'sell to cover' transactions to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Following these transactions, the CEO retains beneficial ownership of 434,357 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sales were executed under a pre-arranged 10b5-1 plan and included mandatory tax-related sell-to-cover transactions.
Positives
- The sales were conducted under a pre-established Rule 10b5-1 trading plan, indicating the transactions were not based on sudden non-public information.
Negatives
- The sale represents a reduction in the CEO's direct equity stake in the company.
Risks
- Insider selling can sometimes be perceived negatively by the market as a signal of management's view on current valuation.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Management Comments
- The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the range upon request.
Industry Context
StockSavvy.ai notes that executive selling under 10b5-1 plans is a standard corporate practice for liquidity and tax management, and is generally viewed as neutral by institutional investors when pre-planned.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for executives to manage equity holdings while avoiding potential insider trading concerns.
Stakeholder Impact
- Shareholders should note the reduction in insider ownership, though the structured nature of the sale mitigates concerns regarding management confidence.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 05/11/2026 | Date of initial share sale transaction. |
| 05/12/2026 | Date of secondary share sale transaction. |
| 05/13/2026 | Date of filing signature. |
Keywords
Privia Health Group, PRVA, Insider Trading, Form 4, CEO, Equity Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.